Audit of three antimuscarinic drugs for managing retained secretions.
Hughes
A
A
Hayward House Macmillan Specialist Palliative Care Unit, Nottingham City Hospital NHS Trust, UK.
Wilcock
A
A
Corcoran
R
R
Lucas
V
V
King
A
A
D012634:Bodily Secretions / Q000187:drug effects*; D006024:Glycopyrrolate / Q000627:therapeutic use*; D006801:Humans; D008485:Medical Audit; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D010166:Palliative Care / Q000379:methods; D017410:Practice Guidelines as Topic / Q000592:standards*; D011446:Prospective Studies; D012601:Scopolamine / Q000627:therapeutic use*; D013727:Terminal Care / Q000379:methods*
D018727:Muscarinic Antagonists; D012601:Scopolamine; D006024:Glycopyrrolate